Skip to main content
Erschienen in: Supportive Care in Cancer 2/2020

03.06.2019 | Original Article

Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy

verfasst von: Rina S. Fox, Sonia Ancoli-Israel, Scott C. Roesch, Erin L. Merz, Sarah D. Mills, Kristen J. Wells, Georgia Robins Sadler, Vanessa L. Malcarne

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Sleep disturbance and cancer-related fatigue (CRF) are among the most commonly reported symptoms associated with breast cancer and its treatment. This study identified symptom cluster groups of breast cancer patients based on multidimensional assessment of sleep disturbance and CRF prior to and during chemotherapy.

Methods

Participants were 152 women with stage I–IIIA breast cancer. Data were collected before chemotherapy (T1) and during the final week of the fourth chemotherapy cycle (T2). Latent profile analysis was used to derive groups of patients at each timepoint who scored similarly on percent of the day/night asleep per actigraphy, the Pittsburgh Sleep Quality Index global score, and the five subscales of the Multidimensional Fatigue Symptom Inventory-Short Form. Bivariate logistic regression evaluated if sociodemographic/medical characteristics at T1 were associated with group membership at each timepoint.

Results

Three groups (Fatigued with sleep complaints, Average, Minimal symptoms) were identified at T1, and five groups (Severely fatigued with poor sleep, Emotionally fatigued with average sleep, Physically fatigued with average sleep, Average, Minimal symptoms) at T2. The majority of individuals in a group characterized by more severe symptoms at T1 were also in a more severe symptom group at T2. Sociodemographic/medical variables at T1 were significantly associated with group membership at T1 and T2.

Conclusions

This study identified groups of breast cancer patients with differentially severe sleep disturbance and CRF symptom profiles prior to and during chemotherapy. Identifying groups with different symptom management needs and distinguishing groups by baseline sociodemographic/medical variables can identify patients at risk for greater symptom burden.
Literatur
1.
Zurück zum Zitat Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR (2010) Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 28(2):292–298. https://doi.org/10.1200/JCO.2009.22.5011 CrossRefPubMed Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR (2010) Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 28(2):292–298. https://​doi.​org/​10.​1200/​JCO.​2009.​22.​5011 CrossRefPubMed
3.
Zurück zum Zitat Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C, National comprehensive cancer network (2015) Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw 13(8):1012–1039CrossRef Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C, National comprehensive cancer network (2015) Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw 13(8):1012–1039CrossRef
4.
Zurück zum Zitat de Jong N, Courtens AM, Abu-Saad HH, Schouten HC (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25(4):283–297CrossRefPubMed de Jong N, Courtens AM, Abu-Saad HH, Schouten HC (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25(4):283–297CrossRefPubMed
11.
12.
Zurück zum Zitat Doong SH, Dhruva A, Dunn LB, West C, Paul SM, Cooper BA, Elboim C, Abrams G, Merriman JD, Langford DJ, Leutwyler H, Baggott C, Kober K, Aouizerat BE, Miaskowski C (2015) Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biol Res Nurs 17(3):237–247. https://doi.org/10.1177/1099800414550394 CrossRefPubMed Doong SH, Dhruva A, Dunn LB, West C, Paul SM, Cooper BA, Elboim C, Abrams G, Merriman JD, Langford DJ, Leutwyler H, Baggott C, Kober K, Aouizerat BE, Miaskowski C (2015) Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biol Res Nurs 17(3):237–247. https://​doi.​org/​10.​1177/​1099800414550394​ CrossRefPubMed
14.
Zurück zum Zitat Miaskowski C, Cooper BA, Melisko M, Chen LM, Mastick J, West C, Paul SM, Dunn LB, Schmidt BL, Hammer M, Cartwright F, Wright F, Langford DJ, Lee K, Aouizerat BE (2014) Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy. Cancer 120(15):2371–2378. https://doi.org/10.1002/cncr.28699 CrossRefPubMed Miaskowski C, Cooper BA, Melisko M, Chen LM, Mastick J, West C, Paul SM, Dunn LB, Schmidt BL, Hammer M, Cartwright F, Wright F, Langford DJ, Lee K, Aouizerat BE (2014) Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy. Cancer 120(15):2371–2378. https://​doi.​org/​10.​1002/​cncr.​28699 CrossRefPubMed
24.
Zurück zum Zitat Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26(3):342–392CrossRefPubMed Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26(3):342–392CrossRefPubMed
26.
Zurück zum Zitat Lichstein KL, Stone KC, Donaldson J, Nau SD, Soeffing JP, Murray D, Lester KW, Aguillard RN (2006) Actigraphy validation with insomnia. Sleep 29(2):232–239PubMed Lichstein KL, Stone KC, Donaldson J, Nau SD, Soeffing JP, Murray D, Lester KW, Aguillard RN (2006) Actigraphy validation with insomnia. Sleep 29(2):232–239PubMed
27.
Zurück zum Zitat Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213CrossRefPubMed Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213CrossRefPubMed
28.
Zurück zum Zitat Stein KD, Martin SC, Hann DM, Jacobsen PB (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6(3):143–152CrossRefPubMed Stein KD, Martin SC, Hann DM, Jacobsen PB (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6(3):143–152CrossRefPubMed
29.
Zurück zum Zitat Stein KD, Jacobsen PB, Blanchard CM, Thors C (2004) Further validation of the Multidimensional Fatigue Symptom Inventory-Short Form. J Pain Symptom Manag 27(1):14–23CrossRef Stein KD, Jacobsen PB, Blanchard CM, Thors C (2004) Further validation of the Multidimensional Fatigue Symptom Inventory-Short Form. J Pain Symptom Manag 27(1):14–23CrossRef
31.
Zurück zum Zitat Muthén LK, Muthén BO (1998-2011) Mplus User’s guide. Sixth edition. Muthén & Muthén, Los Angeles Muthén LK, Muthén BO (1998-2011) Mplus User’s guide. Sixth edition. Muthén & Muthén, Los Angeles
32.
Zurück zum Zitat Enders CK (2010) Applied missing data analysis. Guilford Press, New York Enders CK (2010) Applied missing data analysis. Guilford Press, New York
34.
Zurück zum Zitat Schwarz G (1978) Estimating the dimension of a model. Ann Stat 6(2):461–464CrossRef Schwarz G (1978) Estimating the dimension of a model. Ann Stat 6(2):461–464CrossRef
36.
Zurück zum Zitat McLachlan G, Peel D (2004) Finite mixture models. John Wiley & Sons McLachlan G, Peel D (2004) Finite mixture models. John Wiley & Sons
37.
Zurück zum Zitat Ramaswamy V, DeSarbo WS, Reibstein DJ, Robinson WT (1993) An empirical pooling approach for estimating marketing mix elasticities with PIMS data. Mark Sci 12(1):103–124CrossRef Ramaswamy V, DeSarbo WS, Reibstein DJ, Robinson WT (1993) An empirical pooling approach for estimating marketing mix elasticities with PIMS data. Mark Sci 12(1):103–124CrossRef
39.
Zurück zum Zitat Edinger JD, Bonnet MH, Bootzin RR, Doghramji K, Dorsey CM, Espie CA, Jamieson AO, McCall W, Morin CM, Stepanski EJ, American Academy of Sleep Medicine Work Group (2004) Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 27(8):1567–1596CrossRefPubMed Edinger JD, Bonnet MH, Bootzin RR, Doghramji K, Dorsey CM, Espie CA, Jamieson AO, McCall W, Morin CM, Stepanski EJ, American Academy of Sleep Medicine Work Group (2004) Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 27(8):1567–1596CrossRefPubMed
45.
Zurück zum Zitat Hwang SS, Chang VT, Rue M, Kasimis B (2003) Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manag 26(1):604–614CrossRef Hwang SS, Chang VT, Rue M, Kasimis B (2003) Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manag 26(1):604–614CrossRef
46.
Zurück zum Zitat Onen SH, Onen F, Courpron P, Dubray C (2005) How pain and analgesics disturb sleep. Clin J Pain 21(5):422–431CrossRefPubMed Onen SH, Onen F, Courpron P, Dubray C (2005) How pain and analgesics disturb sleep. Clin J Pain 21(5):422–431CrossRefPubMed
Metadaten
Titel
Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy
verfasst von
Rina S. Fox
Sonia Ancoli-Israel
Scott C. Roesch
Erin L. Merz
Sarah D. Mills
Kristen J. Wells
Georgia Robins Sadler
Vanessa L. Malcarne
Publikationsdatum
03.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04834-w

Weitere Artikel der Ausgabe 2/2020

Supportive Care in Cancer 2/2020 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.